Baker Bros. Advisors’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Hold |
|
|||||
|
2025
Q1 | $3.84M | Hold |
|
|||||
|
2024
Q4 | $8.47M | Hold |
|
|||||
|
2024
Q3 | $13.9M | Hold |
|
|||||
|
2024
Q2 | $16.3M | Hold |
|
|||||
|
2024
Q1 | $22.1M | Hold |
|
|||||
|
2023
Q4 | $16.2M | Hold |
|
|||||
|
2023
Q3 | $7.13M | Hold |
|
|||||
|
2023
Q2 | $6.96M | Hold |
|
|||||
|
2023
Q1 | $5.85M | Hold |
|
|||||
|
2022
Q4 | $4.32M | Hold |
|
|||||
|
2022
Q3 | $8.49M | Hold |
|
|||||
|
2022
Q2 | $8.76M | Buy |
|
|||||
|
2022
Q1 | $3.99M | Hold |
|
|||||
|
2021
Q4 | $6.41M | Hold |
|
|||||
|
2021
Q3 | $11.9M | Buy |
|